Study S001659

Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients With Type 2 Diabetes Mellitus: A Prospective, Multicenter, Randomized, Blank-controlled，Blinded End-point Study.

Included trial: extracted data ClinicalTrials.gov record

Registration

Registration: NCT03948347
Acronym: LAMP
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: SINGLE
Status: UNKNOWN
Enrollment: 1708
Start: 2019-06-25
Primary completion: 2023-12
Lead sponsor: First Affiliated Hospital of Jinan University
Conditions: Ischemic Stroke; Transient Ischemic Attack; Type 2 Diabetes Mellitus
Interventions: DRUG:Liraglutide
Results posted: FALSE

Registered primary outcomes

Percentage of patients with the 90-day new stroke events (ischemic or hemorrhagic) [90 days]

Linked records (2)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0002274	Liraglutide and Recurrent Stroke by Baseline Insulin Resistance: A Post Hoc Analysis of the LAMP Trial. Lu L, Stroke	2026	Randomized trial	PMID 42145088 DOI	cites ClinicalTrials.gov:NCT03948347; registry reference DERIVED:42145088
R0005689	Liraglutide in Acute Minor Ischemic Stroke or High-Risk Transient Ischemic Attack With Type 2 Diabetes: The LAMP Randomized Clinical Trial. Zhu H, JAMA internal medicine	2026	Randomized trial	PMID 41182740 DOI	cites ClinicalTrials.gov:NCT03948347; registry reference DERIVED:41182740